Thank you for a great 2018 Meeting!

 Feb 27 – March 2 | Marco Island, FL

Advances in Genome Biology and Technology (AGBT) 

The General Meeting is our flagship event

The General Meeting brings together technology, software, applications, data resources and public policy. AGBT provides a forum for exchanging information about the latest advances in DNA sequencing technologies, experimental and analytical approaches for genomic studies, and their myriad applications.

AGBT 2019 applications for registration
and call for abstracts opens in October of 2018

See The
See The
See The
See The
Registration

AGBT 2019 applications for registration opens in October of 2018


AGBT 2019 will be held at

JW Marco Marriott Resort in Marco Island, FL

Feb 27th – March 2nd, 2019

For registration questions, contact the Registrar directly:

1.800.266.0866 or registrar@nixassoc.com
Abstracts

AGBT 2019 call for abstracts
begins in October of 2018

Location
JW Marco Marriott Resort
Marco Island, FL

 

2018 Demographics

Attendees

Universities And Nonprofits

Companies

CEOS, CMOS, and CSOS

  • North America
  • Europe
  • Asia
  • Africa
  • Australia and New Zealand

2018 COUNTRIES IN ATTENDANCE

Australia | Austria | Belgium | Canada | China | Finland | France

Germany | Israel | Italy | Japan | Kenya | Lithuania | Netherlands

New Zealand | Norway | Qatar | Russia | Singapore | South Africa

Spain | Sweden | Switzerland | Taiwan | United Arab Emirates

United Kingdom | United States

2018 United States Attendees

Attendance 2012–2018

Institutions 2012–2018

For more Information

 

AGBT 2017 General Meeting

The Diplomat Resort
Hollywood Florida

The Co-Chairs for the 2018 AGBT General Meeting are:
Eric Green (National Human Genome Research Institute /National Institute of Health)
Elaine Mardis (The Institute for Genomic Medicine at Nationwide Children’s Hospital)
and Len Pennacchio (Lawrence Berkeley National Laboratory).

The Organizing Committee Includes:
Ken Dewar (McGill University and GОnome QuОbec Innovation Centre) | Federica Di-Palma (Earlham Institute, University of East Anglia) | Christopher Mason (Weill Cornell Medicine)
Robert Lyons, (University of Michigan) | Martin Hirst (University of British Columbia) | John McPherson (University of California Davis)
Beth Shapiro (University of California Santa Cruz) | Michael Zody (New York Genome Center).